J. Stark

710 total citations
30 papers, 457 citations indexed

About

J. Stark is a scholar working on Rheumatology, Immunology and Plant Science. According to data from OpenAlex, J. Stark has authored 30 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 9 papers in Immunology and 4 papers in Plant Science. Recurrent topics in J. Stark's work include Spondyloarthritis Studies and Treatments (10 papers), Psoriasis: Treatment and Pathogenesis (9 papers) and Rheumatoid Arthritis Research and Therapies (9 papers). J. Stark is often cited by papers focused on Spondyloarthritis Studies and Treatments (10 papers), Psoriasis: Treatment and Pathogenesis (9 papers) and Rheumatoid Arthritis Research and Therapies (9 papers). J. Stark collaborates with scholars based in United States, Belgium and Netherlands. J. Stark's co-authors include M.R. van Leeuwen, Jan Dijksterhuis, Robert‐Jan Bleichrodt, H. Stam, Pauline Krijgsheld, Han A. B. Wösten, Hildegard Menke, Sara Stead, Matthew Sharman and Robert Suruki and has published in prestigious journals such as Applied and Environmental Microbiology, Annals of the Rheumatic Diseases and Journal of the American Academy of Dermatology.

In The Last Decade

J. Stark

24 papers receiving 440 citations

Peers

J. Stark

PHARM

RHEUM

Muhammad Waqas Pakistan

Moustafa A. El-Nakeeb Egypt

Marlene Fredborg Denmark

Danijela Apostolović Sweden

Viljemka Bučević‐Popović Croatia

Fazal Akbar Pakistan

Glenn J. Merkel United States

Katsutoshi Takada Japan

Gordon L. Dorn United States

Walaa K. Mousa Egypt

Muhammad Waqas Pakistan

J. Stark

29 ×0.2

PHARM

58 ×0.5

443 ×3.9

71 ×1.0

RHEUM

143 ×2.1

Citations per year, relative to J. Stark J. Stark (= 1×) peers Muhammad Waqas

Countries citing papers authored by J. Stark

Since Specialization

Citations

This map shows the geographic impact of J. Stark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Stark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Stark more than expected).

Fields of papers citing papers by J. Stark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Stark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Stark. The network helps show where J. Stark may publish in the future.

Co-authorship network of co-authors of J. Stark

This figure shows the co-authorship network connecting the top 25 collaborators of J. Stark. A scholar is included among the top collaborators of J. Stark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Stark. J. Stark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Blauvelt, Andrew, et al.. (2024). Impact of Disease Burden of Patients with Psoriasis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry. Dermatology and Therapy. 14(10). 2787–2804.

Blauvelt, Andrew, April W. Armstrong, Joseph F. Merola, et al.. (2024). Mental health outcomes in patients with moderate to severe psoriasis treated with bimekizumab: Analysis of phase 2/3 randomized trials. Journal of the American Academy of Dermatology. 91(1). 72–81. 6 indexed citations

Suruki, Robert, et al.. (2024). Opioid use surrounding diagnosis and follow-up in patients with ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis: Results from US claims databases. Clinical Rheumatology. 43(6). 1897–1907. 3 indexed citations

Lichtenstein, Gary R., Scott D. Lee, Brian G. Feagan, et al.. (2024). Certolizumab Pegol Treatment in Patients With Crohn’s Disease: Final Safety Data From the SECURE Registry. Crohn s & Colitis 360. 7(1). otae083–otae083.

McLean, Robert R., Adam Šíma, Eric A. Jones, et al.. (2023). Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis Registry. Dermatology and Therapy. 13(11). 2753–2768. 5 indexed citations

Blauvelt, Andrew, April W. Armstrong, Joseph F. Merola, et al.. (2023). Bimekizumab in Patients with Moderate to Severe Plaque Psoriasis: Analysis of Mental Health and Associated Disorders. SKIN The Journal of Cutaneous Medicine. 7(6). s300–s300.

McLean, Robert R., Adam Šíma, Rebecca L. Spitzer, et al.. (2023). Skin Clearance is Associated with Reduced Treatment Failure in Patients with Psoriasis: Real-World Evidence from the CorEvitas Psoriasis Registry. Dermatology and Therapy. 13(11). 2739–2751.

Suruki, Robert, et al.. (2021). Occurrence of Possible Rheumatologic Immune-Related Adverse Events (rh-irAEs) Associated with Immune Checkpoint Inhibitor (ICI) Therapy. Rheumatology and Therapy. 8(4). 1651–1659. 1 indexed citations

Hwang, Mark C., et al.. (2020). Content validity of the ASQoL for use in a non-radiographic axial spondyloarthritis population: a qualitative study. Quality of Life Research. 29(11). 3155–3166. 4 indexed citations

10.

Gavigan, Kelly, et al.. (2020). Barriers to treatment optimization and achievement of patients’ goals: perspectives from people living with rheumatoid arthritis enrolled in the ArthritisPower registry. Arthritis Research & Therapy. 22(1). 4–4. 15 indexed citations

11.

Sloan, Victor S., et al.. (2019). Opioid Use in Patients with Ankylosing Spondylitis Is Common in the United States: Outcomes of a Retrospective Cohort Study. The Journal of Rheumatology. 46(11). 1450–1457. 17 indexed citations

12.

Chua, Alicia S., et al.. (2018). Cost Per Response of Certolizumab Pegol Versus Adalimumab Among Biologic-Naïve Patients With Moderate or Severe Rheumatoid Arthritis from the US Payer Perspective. Value in Health. 21. S194–S194.

13.

Walsh, Jessica A., T. Arledge, T. Nurminen, Luke Peterson, & J. Stark. (2018). PGA×BSA: A Measure of Psoriasis Severity Tested in Patients with Active Psoriatic Arthritis and Treated with Certolizumab Pegol. The Journal of Rheumatology. 45(7). 922–928. 5 indexed citations

14.

Harrold, Leslie R., Heather J. Litman, Katherine C. Saunders, et al.. (2018). One-year risk of serious infection in patients treated with certolizumab pegol as compared with other TNF inhibitors in a real-world setting: data from a national U.S. rheumatoid arthritis registry. Arthritis Research & Therapy. 20(1). 2–2. 26 indexed citations

15.

Leeuwen, M.R. van, Pauline Krijgsheld, Timon T. Wyatt, et al.. (2013). The effect of natamycin on the transcriptome of conidia of Aspergillus niger. Studies in Mycology. 74(1). 71–85. 33 indexed citations

16.

Leeuwen, M.R. van, Pauline Krijgsheld, Robert‐Jan Bleichrodt, et al.. (2013). Germination of conidia of Aspergillus niger is accompanied by major changes in RNA profiles. Studies in Mycology. 74(1). 59–70. 105 indexed citations

17.

Leeuwen, M.R. van, et al.. (2010). Water- and air-distributed conidia exhibit differences in sterol content and cytoplasmic microviscosity. Applied and Environmental Microbiology. 67. 366–369. 3 indexed citations

18.

Stead, Sara, et al.. (2007). New method for the rapid identification of tetracycline residues in foods of animal origin — using the Premi®Test in combination with a metal ion chelation assay. Food Additives & Contaminants. 24(6). 583–589. 9 indexed citations

19.

Stead, Sara, et al.. (2004). Meeting maximum residue limits: an improved screening technique for the rapid detection of antimicrobial residues in animal food products. Food Additives & Contaminants. 21(3). 216–221. 61 indexed citations

20.

Li, Xia, et al.. (2001). Plant catechols prevent lipid peroxidation in human plasma and erythrocytes. Molecular and Cellular Biochemistry. 226(1-2). 89–95. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact